Quantcast

Avidas(TM) Pharmaceuticals Introduces Avidoxy(TM) DK, Simplifying Therapy for Millions Suffering from Severe Acne

March 2, 2009

DOYLESTOWN, Pa., March 2 /PRNewswire/ — Avidas(TM) Pharmaceuticals, a privately held, specialty pharmaceutical company which focuses on dermatology, women’s health and endocrinology, today announced the launch of Avidoxy(TM) DK (defence kit), a new patient convenience kit developed to control severe acne by attacking bacteria and by cleansing, exfoliating, moisturizing and protecting skin.

Avidoxy DK includes Avidoxy(TM) (Doxycycline Tablets), a broad spectrum oral antibiotic, in an easy-to-swallow film-coated caplet indicated as adjunctive therapy for severe acne, with complimentary defence(TM) acne wash, a specially formulated oil and alcohol-free acne wash with 2% salicylic acid that provides gentle yet effective cleansing and exfoliation of skin. Avidoxy DK also contains complimentary defence(TM) solare, a lightweight, oil-free, non-comedogenic sunscreen rich in anti-oxidants and moisturizers offering SPF 30+ of broad spectrum sun protection. Avidoxy DK is available by prescription only.

According to the American Academy of Dermatology (AAD), oral antibiotics, such as the active ingredient in Avidoxy, are a mainstay of therapy for severe acne because they reduce the P. acnes bacteria population, a contributing factor in acne. Salicylic acid, which is found in professional strength concentrations with defence acne wash, helps correct the abnormal shedding of skin cells and unclogs pores to resolve and prevent acne lesions. Everyone needs, especially acne patients, protection from the sun’s damage and premature aging. Because many acne treatments can increase the skin’s sensitivity to sunlight and ultraviolet light, the AAD recommends the use of a broad spectrum sunscreen such as that found in defence solare SPF 30+.

“Reduction of bacteria with effective skin cleansing, exfoliation and protection are considered by many physicians to be important treatment arms for the control of severe acne,” states Charles Pamplin III, MD, Chief Medical Advisor for Avidas. “With Avidoxy DK, physicians can provide their patients with a simple and convenient way to treat this serious, yet common, skin condition.”

Important Safety Information:

Avidoxy is indicated as adjunctive therapy for severe acne. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Avidoxy and other antibacterial drugs, Avidoxy should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

The use of drugs of the Tetracycline class during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown).

Please see accompanying full prescribing information

About Acne:

Acne vulgaris (commonly called acne) is a skin disease caused by changes in the pilosebaceous units (skin structures consisting of a hair follicle and its associated sebaceous gland). Severe acne is inflammatory, but acne can also manifest in non-inflammatory forms. Acne lesions are commonly referred to as pimples, spots, zits, or acne.

About Avidas:

Avidas Pharmaceuticals is a privately held company focused on the therapeutic areas of dermatology, women’s health and endocrinology. The company acquires, develops, and maximizes the potential of acquired products through focused selling and precision marketing. The company is headquartered in Doylestown, PA.http://www.avidaspharma.com

Contact:

Avidas Pharmaceuticals, LLC, Greg Gironda, 267-895-1755, greggironda@avidaspharma.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Avidas Pharmaceuticals, LLC


Source: newswire



comments powered by Disqus